Graham Griffiths

All filings by Graham Griffiths on record concern Vaccitech plc, in the capacity of senior executive. Over a trading history stretching from 4 May 2021 to 25 August 2022, the count stands at 11 filings.

The open-market side counts 1 purchase for €1,415 alongside 6 sales for €115k. The net balance comes to €114k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 option exercises. 2022 to date brings no purchases and 6 sales.

The record was last updated on 26 August 2022 with an open-market sale (€74k) in Vaccitech plc. The most recent open-market purchase was published on 6 May 2021, 1,997 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.